Posts Tagged ‘online pharmacyrx’

No More New Molecule For Cardiovascular Ailments as Pharmaceutical Firms Shift Focus

May 30th, 2009 admin

Pharmaceutical Firms Shy away from Cardio Molecule Research Lipitor innovator Pfizer too has shifted focus from Cardiovascular Ailments to other Diseases.

Realpharmacyrx cancer (oncology), diabetes, pain management, chronic obstructive pulmonary disease (COPD) than on heart ailments, which affect over 50 million peoples worldwide

Realpharmacyrx.com: A recent issue of British medical journal The Lancet found that heart diseases kill 3 million people in India annually, accounting for a third of the total deaths in the country. The World Health Organization (WHO) estimates that by 2010, us will have 60% of the world’s heart patients. Hard-hitting facts, these. What’s more alarming is that not much research is being done in UK for developing new molecules in the area of cardiology.

Recently, US pharma giant Pfizer, which focused on cardiovascular diseases (CVD) research, decided to stop the development of new drugs for this segment and shift focus to areas such as Cancer Pills, Diabetes Pills, pain management, Alzheimer’s disease and inflammation. Pfizer is the innovator of blockbuster CVD drugs like Lipitor generic Atorvastatin and Norvasc Generic Amlodipine.  Several leading domestic players are actively engaged in research to develop new chemical entities (NCE) or new biological entities (NBE). An NCE is a chemical molecule discovered and developed by a pharma company, which can become a drug after undergoing clinical trials. On the other hand, an NBE is derived from plants or animals and could become a drug on completion of clinical trials.

Though Indian pharma companies have NCEs and NBEs in the pipeline, the focus seems to be more on segments such as cancer (oncology), diabetes, pain management, chronic obstructive pulmonary disease (COPD) than on heart ailments, which affect over 20 million Indians. Players such as Wockhardt and Dr Reddy’s Laboratories have 2 and 4 NCEs in the pipeline, respectively, but none in cardiology. Likewise, Piramal Life Sciences and Sun Pharmaceuticals Advanced Research Centre (SPARC) have 14 and 4 NCEs, respectively, but again none for heart ailments. “Research in cardiology has plateaued. There are hardly any molecules in cardiology at present.” Indian firms are more inclined towards conducting clinical trials and not developing new molecules. However, Glenmark Pharma has one NBE for CVD, of the 8 NCEs and 5 NBEs it is working on. This molecule is currently in the preclinical stage.

On the other hand, Lupin has some NCEs in the pipeline, and spends 10% of its R&D budget on the cardiovascular space, a spokesperson said.  “Indian players are less focused on cardiology even though India is becoming a major hub for heart-related ailments. Though domestic companies have presence in the cardiovascular market, it is more in the area of process development and analytical research.”

He added that where innovations are concerned, cardiology is a neglected area. Though there seem to be no clear reasons behind the trend, cost and fear of failure could be a couple of causes, say experts. “About 70-80% of heart diseases are preventable with existing medicines. The failure rate of molecules in cardiology is very high and so, for players, it is a major risk.”

“Over 5,000-7,000 patients are needed for phase III trials of a cardiology drug as against 2,000-3,000 for other drugs,” for more information about Blood Pressure Pills, Cholesterol Pills, Diabetes Pills please visit www.realpharmacyrx.com

Posted in Cholesterol Lowering Pills, Generic Drugs Tags: , , , , , , , , , , , , , , , , , , , , No Comments »

Generic products Low price quality generic drugs manufactured by Dr Reddy’s (DRL), Sun pharma, Ranbaxy at realpharmacyrx

May 30th, 2009 admin

Low price quality generic drugs manufactured by Dr Reddy’s (DRL), Sun pharma, Ranbaxy wins 7 drugs for AOK bids Still in the running for 20 more Generic products

low price quality generic drugs anufactured by Dr Reddy's (DRL), Sun pharma, Ranbaxy login at realpharmacyrx

Realpharmacyrx: Dr Reddy’s Laboratories (DRL), the Hyderabad-based pharma major, has gained some ground in the German market by winning a contract to supply seven products to AOK, one of the largest insurers in Germany. DRL had bid for supplying 33 drugs of 64 sought by AOK. For four of the seven it has won, DRL has marketing exclusivity in five regions identified by AOK. For the remaining three, the company will share the market with other pharma players. However, AOK has so far awarded contracts for just 44 molecules of the 64 it seeks. DRL has bid for the remaining 20 molecules too.

A DRL spokesperson said, “We have bid for the other molecules, the results of which are yet to be announced. So, the seven products offered to us are part of the first tranche of bids approved by AOK.”

Company officials disclosed neither the details of the products that will be supplied to AOK, nor their revenue implications. “It’s too early for us to quantify the impact. We are also evaluating the manufacturing details of the products that we will supply to AOK,” the spokesperson said.

DRL has a manufacturing facility near Hyderabad, which it is believed to have readied for manufacturing products for its German arm Betapharm. The company had signed a manufacturing deal with German firm Salutas for Betapharm products but it fell through due to supply issues. DRL then decided to shift the production of Betapharm’s products to India. The move is expected to give it a cost advantage and improved margins. DRL refused to disclose the pricing details of the seven products “due to competitive reasons”.

Meanwhile, analysts feel the bidding might have been aggressive and the pricing of the products may cut into margins significantly. A December 3 report by research firm CLSA said, “The preliminary analysis of AOK tender results indicates decent wins for Dr Reddy’s. It is likely that the company has bid aggressively and won for products where it is cost-competitive. However, delays in tender are possible due to the litigation risks cited earlier by Stada.”

The molecules it has won contracts for, analysts said, would be “where it has reasonable presence like (Generic Prilosec omeprazole (Anti-Acidity (Heartburn) pills), Cholesterol Pills Generic Zocor simvastatin“. “Stada and Ratiopharm (two other pharma majors in the race for the tender) have lost substantially. Stada already mentioned in its recent release that it would litigate against the tender. This will result in further delays,” the report said.

A Citi report dated December 2 too pointed at aggressive pricing but did not make any impact analysis of such pricing. “We believe bidding would have been aggressive, driving significant discounts to current prices. One of DRL’s competitors, Ratiopharm, indicated that it has not received anycontracts and appears to hint at low pricing as a reason. We await further clarity from the management on the net impact (lower pricing, higher volumes in selected products, potentially lower volumes in products where it missed out) before adjusting our estimates,” the Citi report said. for more low price quality generic drugs anufactured by Dr Reddy’s (DRL), Sun pharma, Ranbaxy etc. click here http://www.realpharmacyrx.com/

Posted in Generic Drugs Tags: , , , , , , , , , , No Comments »

Reasons to buy Quality Generic Drugs Online at Realpharmacyrx.com

May 29th, 2009 admin

Reasons to subscribe to Online Pharmacy – Realpharmacyrx (Your Reliable Online Pharmacy for 100% Refine Generic drugs)

1. Convenience: All are agreed that it can be a hassle to go the doctor’s office, and most people are not fond spending a considerable amount of time in the waiting room.

2. Privacy: Consumers can find legitimate online pharmacies offer the privacy and confidentiality, they will want. Ordering drugs online can be very discreet.

3. Doctor’s Review: Many online pharmacies provide prescriptions that are issued, the medical review of the patient’s medical information. Although it may be difficult or embarrassing to talk about certain conditions with a local doctor, it is always best to consult them before any new medication. A complete physical should be done once a year, more than 40 years of age.

4. Not the Trip to the pharmacy: Because consumers can now receive medication delivered directly to their front door, there is no need for them to wait at the local pharmacy, where their conditions have been met.

5. Discounts for re-orders: Many online pharmacies offer discounts and coupons good towards the next order. This is a huge perk for all consumers, not the traditional local pharmacy offers such discounts Oral Viagra jelly UK at cheap prices, buy cheap Generic Viagra Kamagra , kamagra oral jellies online Online without prescription at Cheaper prices.

In the modern internet age we live in, is now more choices for consumers when it comes to ordering prescription drugs online Buy ED Trial Erection Packs , Order Generic Viagra at Cheaper prices.

Most people dread having to make a mobile medical office expects a waiting room for hours, and then spending even more time to consult your doctor. Then there is a mobile pharmacy. This could be a long, drawn-making process only to get needed prescription drugs. However, the Internet presents a lot easier way to get many of the prescription drug ads that we need. All of these will take on the door, and ordered all the comfort, convenience and privacy of your own home. When it comes down to it, people are just a way to supplement the small amount of free time, they are in their busy lives.

Not All Online Pharmacies are the same:

Although it seems that there are a number of online pharmacies touting all sorts of prices and deals have been the case, buyers beware! There is a lot of legal and legitimate pharmacies, but you always want to make sure you know where you are ordering your drugs.

Many of these online pharmacies are illegal operations located abroad. Many of them abandon the FDA approved by the fake, potentially harmful versions of brand-name drugs they do not have permission to produce.

Know Where to Order Online:

The best way to ensure that you are dealing with legitimate online pharmacies to check each of the following:

• Corporate / pharmacy is located in the U.S.

• A U.S. phone number and address is to provide a site

• Company / pharmacy to use US-licensed physicians and pharmacists

• All drugs are FDA approved Generic Viagra, Kamagra, Caverta, Levitra, Kamagra Oral Jelly at Cheaper prices.

• Prospective patients must meet the medical / health questionnaire

• The site is protected by SSL / encrypted

It is important that a secure order online pharmacies order drugs you need. Legitimate pharmacies that provide valid prescription, and ship your drugs quickly and safely.

Remember: Always do research and ensure that you are planning to get brand-name drugs you need. The best way to do this is to talk about the person’s phone. If the site is just an email address and telephone number, it is best to stay away. Online convenience makes sense only if you do not have to worry about who you are dealing with. When you create a solid relationship with the online pharmacy, then obviously the confidence factor is no longer a concern forward Order now Viagra jelly with ED Trial Erection Packs, Buy Cheap Generic Viagra Online without prescription fastest shipping at Realpharmacyrx.com

Posted in Erectile Dysfunction (ED), Generic Drugs, Generic Viagra Sildenafil Citrate, Male Impotence, Male Sexual Health, Ranbaxy Caverta - Generic Viagra Tags: , , , , , No Comments »

Pfizer buy Wyeth for $ 60 billion makes annual sales of more than $ 70 billion – Realpharmacyrx

May 29th, 2009 admin

Will Pfizer buy Wyeth for $ 60 billion if yes than the combination would create a drug maker with annual sales of more than $ 70 billion – Realpharmacyrx.com

Online Pharmacy Realpharmacyrx.com – Pfizer Inc, the World’s largest drug maker is in talks to buy Wyeth in an attempt to replace the revenues expected to lose to generic competition in three years, according to a person familiar with the discussions. Both companies are U.S. based.
The deal could be worth as much as $ 60 billion, the Wall Street Journal reported earlier.
A combination would create a drug maker with annual sales of more than $ 70 billion and best-selling medicines, including cholesterol pill Lipitor and Prevn vaccine against pneumonia.

Pfizer CEO Jeffrey Kindler, 52, is already a reorganization to accelerate drug development and plans to fire personnel recession threatens to crimp sales. By acquiring Wyeth, Pfizer earnings may fall as low as 10% instead of 23% when it loses patent protection in 2011 on its Heart and Cholesterol Pills (Lipitor, Zocor) Quality and brand equivalent Generics drugs instead of Brands, which accounts for one fourth of their income, “said Deutsche Bank analyst Barbara Ryan in a note to customers on Friday.

Lipitor, the world’s best-selling medicine, generated $ 12.7 billion in sales for Pfizer in 2007. “Wyeth is perhaps the most levy play assuming that it will at least some big pharma consolidation over the next one to three years,” says Tim Anderson, analyst at Sanford Bernstein & Co., in a note to clients on Thursday. “The relative lack of a patent can help cut the Smoth hearings for the companies that are not as fortunate.”

An agreement would be the largest pharmaceutical acquisition of at least five years and may signal consolidation in the pharmaceutical industry.

Posted in Cholesterol Lowering Pills, Generic Drugs Tags: , , , , No Comments »
RSS FeedSubscribe to our RSS feed!
Follow me on Twitter!Follow me on Twitter!

  • Featured Video